Bristol-Myers Squibb Company (BMY) has the market capitalization of $93.56 Billion. The stock rose 1.76% or $0.99 reaching $57.29 per share. Another trade for 34,000 shares valued at $1.91M was made by ANDREOTTI LAMBERTO …
Bristol Myers Squibbco now has $94.49B valuation. Muhlenkamp Inc invested in 3.3% or 178,961 shares. It has underperformed by 39.89% the S&P500. The institutional investor owned 4,543 shares of the biopharmaceutical …
Bristol-Myers Squibb Company on 6/29/2017 reported its EPS as $0.77 with the …
It has underperformed by 39.89% the S&P500. Bristol-Myers Squibb Company …
Tenneco Inc now has $2.97B valuation. The share price as presented is an accounting quirk resulting from the total outstanding shares a company's board of directors has permitted to exist through its use of things such as stock splits. …
Denver Investment Advisors Llc sold 52,851 shares as Bristol (BMY)'s stock declined 1.04%. Philadelphia Trust Co. now owns 20,924 shares of the biopharmaceutical company's stock valued at $1,223,000 after buying an additional 1,500 …
Relative Strength Index (RSI) for Bristol-Myers Squibb Company (BMY) is at …
On August 09 th, 2017, research firm Investec upgraded the company's stock
On August 03, 2017, Bristol-Myers Squibb and IFM Therapeutics announced that they have signed a definitive agreement under which the former will acquire all of the outstanding capital stock of the latter, a venture-backed biotech company …
Over the last three months, the shares of the company have changed -10.59% and performed -1.30% over the last six months. Swiss National Bank now owns 5,921,670 shares of the biopharmaceutical company's stock valued at …